US CIP US20080108647 is a continuation-in-part based on the original patent describing cannabinoids useful in the treatment of a variety of diseases, foremost of which is HIV.  The claims include a number of compounds not described in the Markush structure and other novel cannabinoids developed by others who did not claim their use for HIV disease.